GW&K Investment Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

GW&K Investment Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-330,621	Closed	-$9.24M	–	385
2019 Q3	$9.24M	Buy	330,621 +168,023	+103%	+$2.72M	0.13%	208
2019 Q2	$2.29M	Sell	162,598 -1,391	-0.8%	-$13.2K	0.03%	273
2019 Q1	$1.46M	Sell	163,989 -14,547	-8%	-$118K	0.02%	244
2018 Q4	$1.35M	Sell	178,536 -23,089	-11%	-$372K	0.03%	226
2018 Q3	$4.23M	Buy	201,625 +56,926	+39%	+$1.36M	0.07%	215
2018 Q2	$4.33M	Buy	144,699 +1,804	+1%	+$49.1K	0.07%	216
2018 Q1	$3.88M	Buy	+142,895	New	+$4.27M	0.07%	217

GW&K Investment Management's DOVA Position: Q4 2019 in Review

GW&K Investment Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 330,621 shares — an estimated $9.24M sold.

GW&K Investment Management first reported a position in DOVA in Q1 2018 and held it in 7 quarters. The position peaked at $9.24M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

GW&K Investment Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
GW&K Investment Management sold 330,621 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $9.24M.
GW&K Investment Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
GW&K Investment Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $9.24M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on GW&K Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.